116 related articles for article (PubMed ID: 35681020)
1. Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells.
Zaffran I; Landolina N; Gaur P; Rovis TL; Jonjic S; Mandelboim O; Singer BB; Levi-Schaffer F
Cancer Gene Ther; 2022 Nov; 29(11):1676-1685. PubMed ID: 35681020
[TBL] [Abstract][Full Text] [Related]
2. Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions.
Ortenberg R; Sapir Y; Raz L; Hershkovitz L; Ben Arav A; Sapoznik S; Barshack I; Avivi C; Berkun Y; Besser MJ; Ben-Moshe T; Schachter J; Markel G
Mol Cancer Ther; 2012 Jun; 11(6):1300-10. PubMed ID: 22466331
[TBL] [Abstract][Full Text] [Related]
3. The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway.
Fantini M; David JM; Annunziata CM; Morelli MP; Arlen PM; Tsang KY
Cancer Biother Radiopharm; 2020 Apr; 35(3):190-198. PubMed ID: 31928422
[No Abstract] [Full Text] [Related]
4. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
[TBL] [Abstract][Full Text] [Related]
5. The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.
Laurent S; Queirolo P; Boero S; Salvi S; Piccioli P; Boccardo S; Minghelli S; Morabito A; Fontana V; Pietra G; Carrega P; Ferrari N; Tosetti F; Chang LJ; Mingari MC; Ferlazzo G; Poggi A; Pistillo MP
J Transl Med; 2013 May; 11():108. PubMed ID: 23634660
[TBL] [Abstract][Full Text] [Related]
6. Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture.
Gu A; Tsark W; Holmes KV; Shively JE
Exp Cell Res; 2009 Jun; 315(10):1668-82. PubMed ID: 19285068
[TBL] [Abstract][Full Text] [Related]
7. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function.
Nakajima A; Iijima H; Neurath MF; Nagaishi T; Nieuwenhuis EE; Raychowdhury R; Glickman J; Blau DM; Russell S; Holmes KV; Blumberg RS
J Immunol; 2002 Feb; 168(3):1028-35. PubMed ID: 11801635
[TBL] [Abstract][Full Text] [Related]
8. The human antibody fragment DIATHIS1 specific for CEACAM1 enhances natural killer cell cytotoxicity against melanoma cell lines in vitro.
Dupuis ML; Fiori V; Soriani A; Ricci B; Dominici S; Moricoli D; Ascione A; Santoni A; Magnani M; Cianfriglia M
J Immunother; 2015; 38(9):357-70. PubMed ID: 26448580
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia Inhibits Proliferation of Human Dermal Lymphatic Endothelial Cells via Downregulation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 Expression.
Xie Q; Shang TY; Feng S; Zhan RC; Liang J; Fan MG; Zhang L; Liu J
Curr Med Sci; 2021 Dec; 41(6):1192-1197. PubMed ID: 34846700
[TBL] [Abstract][Full Text] [Related]
10. CEACAM1 is a potent regulator of B cell receptor complex-induced activation.
Greicius G; Severinson E; Beauchemin N; Obrink B; Singer BB
J Leukoc Biol; 2003 Jul; 74(1):126-34. PubMed ID: 12832451
[TBL] [Abstract][Full Text] [Related]
11. CEACAM1 promotes melanoma cell growth through Sox-2.
Ortenberg R; Galore-Haskel G; Greenberg I; Zamlin B; Sapoznik S; Greenberg E; Barshack I; Avivi C; Feiler Y; Zan-Bar I; Besser MJ; Azizi E; Eitan F; Schachter J; Markel G
Neoplasia; 2014 May; 16(5):451-60. PubMed ID: 24931667
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions.
Markel G; Seidman R; Stern N; Cohen-Sinai T; Izhaki O; Katz G; Besser M; Treves AJ; Blumberg RS; Loewenthal R; Mandelboim O; Orenstein A; Schachter J
J Immunol; 2006 Nov; 177(9):6062-71. PubMed ID: 17056532
[TBL] [Abstract][Full Text] [Related]
13. SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects.
Rosenbaum SR; Tiago M; Caksa S; Capparelli C; Purwin TJ; Kumar G; Glasheen M; Pomante D; Kotas D; Chervoneva I; Aplin AE
Cell Rep; 2021 Dec; 37(10):110085. PubMed ID: 34879275
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.
Stern N; Markel G; Arnon TI; Gruda R; Wong H; Gray-Owen SD; Mandelboim O
J Immunol; 2005 Jun; 174(11):6692-701. PubMed ID: 15905509
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
Lu R; Kujawski M; Pan H; Shively JE
Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation.
Kammerer R; Stober D; Singer BB; Obrink B; Reimann J
J Immunol; 2001 Jun; 166(11):6537-44. PubMed ID: 11359805
[TBL] [Abstract][Full Text] [Related]
17. MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma.
Ullrich N; Löffek S; Horn S; Ennen M; Sánchez-Del-Campo L; Zhao F; Breitenbuecher F; Davidson I; Singer BB; Schadendorf D; Goding CR; Helfrich I
Pigment Cell Melanoma Res; 2015 Nov; 28(6):736-40. PubMed ID: 26301891
[TBL] [Abstract][Full Text] [Related]
18. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling.
Hosomi S; Chen Z; Baker K; Chen L; Huang YH; Olszak T; Zeissig S; Wang JH; Mandelboim O; Beauchemin N; Lanier LL; Blumberg RS
Eur J Immunol; 2013 Sep; 43(9):2473-83. PubMed ID: 23696226
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function.
Chen D; Iijima H; Nagaishi T; Nakajima A; Russell S; Raychowdhury R; Morales V; Rudd CE; Utku N; Blumberg RS
J Immunol; 2004 Mar; 172(6):3535-43. PubMed ID: 15004154
[TBL] [Abstract][Full Text] [Related]
20. In vivo CD40 ligation can induce T-cell-independent antitumor effects that involve macrophages.
Lum HD; Buhtoiarov IN; Schmidt BE; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
J Leukoc Biol; 2006 Jun; 79(6):1181-92. PubMed ID: 16565324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
